Halozyme and Skye partner on obesity drug delivery technology
Go back to Halozyme and Skye partner on obesity drug delivery technology| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 106.12 -1.5 (1.39%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $107.62 | 52 Week High | $18.39 | |||
| Open | $106.41 | 52 Week Low | $6.96 | |||
| Day High | $107.44 | P/E | N/A | |||
| Day Low | $105.20 | EPS | $-0.58 | |||
| Volume | 1,577,785 | |||||
| (NASDAQ: SKYE) | Delayed: 0.28 -0.03 (9.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.31 | 52 Week High | $ | |||
| Open | $0.30 | 52 Week Low | $ | |||
| Day High | $0.33 | P/E | N/A | |||
| Day Low | $0.28 | EPS | $ | |||
| Volume | 1,596,282 | |||||
